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1. Introduction 
Obesity is currently regarded as one of the most alarming pandemic diseases worldwide as 
it is closely related to, and in many cases causative of, Type 2 Diabetes (T2D), coronary heart 
disease (CHD), cancer and other pathophysiological disturbances. A cluster of these 
disorders are linked together under the term Metabolic Syndrome (MetS). These factors 
include impaired glucose tolerance and/or insulin resistance, dyslipidemia (high plasma 
levels of triglycerides and low density lipoproteins), central obesity and hypertension [1]. In 
the USA a recent Health and Nutrition Examination Survey (NHANES) reported that 68.3% 
of study subjects were considered as overweight (BMI  25) and 33.9% obese (BMI  30) [2]. 
The rising incidence of childhood obesity and T2D, high blood pressure, hyperinsulinemia 
and dyslipidemia are particularly worrisome as these children often mature to be obese 
adults [3]. This risk of developing obesity and T2D has largely been blamed on the increased 
consumption of energy dense foods and fat intake, particularly saturated fat, but it is 
interesting to know that the mean fat intake of the human population has not increased 
much in the past 50 years [4]. It is true that the vast advancement in technological 
developments has led to a reduction in physical activity worldwide, but as obesity now 
involves infants and the populations of developing countries [5], this obesity pandemic 
cannot be attributed to this alone. In addition, laboratory and other domesticated animals 
have also been subject to the increased prevalence of obesity, despite having largely 
unchanged living conditions for many years [5]. 
Obesity and MetS have nevertheless been blamed on excess intake of fat leading to excess 
energy intake exceeding energy expenditure, which causes the deposition of this energy in 
the format of greater numbers of excessively enlarged fat cells. When this fat deposition 
occurs in the central trunk (visceral fat accumulation) it is highly causative and suggestive of 
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the risk of developing MetS, due to associated high levels of blood cholesterol and 
triglycerides [6]. It is especially dietary saturated fat acid (SFA) consumption that has been 
thought to lead to the elevation of these blood factors which are highly indicative of CHD 
risk. Most recently, through meta-analyses of large international studies, the consumption of 
SFA has been de-vilified and the causal link between these parameters and CHD disproven 
[7-9]. The question thus arises which changes in the dietary composition in the past half-
century is causing this obesogenic outcome? Although the total fat content of the diet has 
not changed significantly, a growing number of reports are making it quite clear that the 
dietary fatty acid quality may be responsible for the differential influence on obesity and 
pathophysiological outcome.  
The main alteration within the fatty acid profile of the modern diet has been the increased 
use of vegetable oil, both as a cheaper and more accessible alternative to animal fats, but 
also as a substitute to animal fats to reduce the intake of SFAs. Vegetable oils, although 
higher in monounsaturated fatty acids, are very high in omega-6 fatty acids (100-fold larger) 
compared with animal fat [10]. These oils are also much lower in omega-3 fatty acids, 
leading to an increase in the ratio of dietary omega-6:omega-3 fatty acids. In the past few 
years a growing number of studies and meta-analyses have focused on the influence of 
dietary omega-6:omega-3 ratio, and the role of omega-3 fatty acids in the development of 
T2D and CHD [11-13] and a clear link between a high ratio of omega-6:omega-3 fatty acids 
and the development of these pathologies illustrated (Fig. 1). These effects are, to a large 
extent, believed to be due to the pro-inflammatory functions of the omega-6 arachidonic 
acid (AA) cascade which has deleterious effects in a variety of tissues due to chronic low-
grade systemic inflammation. This inflammatory environment is now considered a key 
component of MetS, as the enlarged adipocytes are known to secrete many relevant pre-
inflammatory adipokines [14]. These pro-inflammatory adipokines are to a great extent 
responsible for insulin resistance, hallmarked by decreased fatty acid oxidation and an 
increase in triglyceride and free fatty acid (FFA) synthesis. These FFAs are then deposited 
within the adipocytes, leading to and worsening obesity and the perpetual further effect on 
metabolic dysregulation of fat and glucose homeostasis. Conversely, the omega-3 fatty acids 
eicosapentanoic acid (EPA) and docohexanoic acid (DHA) have anti-inflammatory 
properties, and serve as protection against MetS and CHD [15]. In adipocytes, these omega-3 
fatty acids prevent insulin resistance mediated by the AA-induced increase in pro-
inflammatory eicosanoids, via modulation of adiponectin levels and function [16-18]. This 
positive effect can only occur when an excess of omega-6 fatty acids is not present, as high 
levels of omega-6 fatty acids prevent the synthesis of omega-3 fatty acids in tissues [19], and 
it is thus arguable whether supplementation or dietary increase of omega-3 fatty acids 
would effectively attenuate the deleterious effects of omega-6 mediated inflammatory 
mechanisms without a decrease in the intake of omega-6 fatty acids [20-22]. 
Close scrutiny of the modern Western diet in epidemiological studies have brought to 
attention the role of the fatty acid profile of certain native and regional diets in the 
prevention of the development of MetS and all of its associated symptoms [8, 9, 23, 24]. In 
populations consuming diets rich in omega-3 fatty acids, the prevalence of impaired glucose 
tolerance and CHD is much lower than those populations consuming the Western diet.  
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Figure 1. The role of dietary omega-6:omega-3 ratio on the development of obesity, T2D and CHD. 
Japanese island-dwellers and Alaskan natives, who adopt the Western diets through 
migration, forsake the consumption of their native high omega-3 foods in lieu of high 
omega-6 Western foods leading to as much as an 80% increase in T2D. Icelandic natives 
have a very low incidence of T2D, despite their high prevalence of overweight and obesity 
[25], found to be due to an inverse association with the omega-3 content of reindeer milk, 
and thus positively associated with its omega-6:omega-3 fatty acid ratio. Furthermore, 
Icelandic animal fodder contains fish meal which greatly reduces the omega-6:omega-3 
content of the milk, and this provides a protective factor against MetS and T2D. This is 
contrast to other Norwegian countries, as well the rest of the Western world, where animal 
fodder contains high amounts of omega-6 fatty acids.  
Animal feeds were also subject to the change from a low to high omega-6 content with the 
incorporation of vegetable oils, and this has led to and increase in obesity in domestic and 
laboratory animals [5]. Laboratory animals, whose housing and husbandry practices have 
no changed much in the last 50 years, now have a much increased mid-life bodyweight.  
This is proposed to be due to the substitution of dietary fat source from lard to soy bean oil 
(or soy meal) and hence the omega-6:omega-3 ratio has increased from 2:1 to 12.5:1 [26]. This 
is very concerning as these feeds serve as control and maintenance diets and are utilized in 
most rodent research colonies worldwide. Maternal programming is a well-described field, 
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especially in the development of T2D, and animals exposed to pro-diabetic diets during 
pregnancy give rise to offspring with a higher propensity of developing metabolic 
perturbations [27]. The ‘control’ diet used in the majority of studies thus in fact may 
represent a high omega-6 treatment diet, which casts a degree of doubt on the accuracy of 
results obtained from such experiments. More careful scrutiny and transparency of rodent 
dietary composition is needed in order to make valid comparisons with other dietary 
interventions in the study of MetS components.  
Animal models of MetS are not only influenced by dietary fatty acid composition, and other 
husbandry-associated factors such as day/night cycle and time-of-day experimental 
procedures can also influence the outcome of such studies. Rodents, by nature, are 
nocturnally active animals, but sampling and experimental procedures commonly take 
place in the day time which is the inactive rest phase of these animals. The circadian clock, 
which is regulated by daylight exposure, plays a critical role in many physiological 
processes associated with insulin, fatty acid and glucose metabolism. In the rat, insulin 
levels are low during its inactive diurnal phase, and high during the nocturnal phase with 
high glucose utilization [28]. Sampling of blood and performance of glucose tolerance tests 
usually take place in the morning, as it represents the most convenient time for the scientist, 
following a 6-12 h overnight fast during the animal’s active phase. This causes a rapid fall in 
blood glucose levels, whereas fasting during the day in the animal’s rest phase causes a 
much less significant drop in blood glucose levels. In addition, stress induction due to this 
food deprivation, causes a rise in corticosteroid levels which mobilizes fatty acids from 
triglyceride stores [29] giving an inaccurate reflection of the blood levels of these 
compounds. This of course is not desirable in an experimental setting and undue bias is 
incorporated. A solution is to reverse the light-dark cycle, so that all animal procedures are 
carried out during the animal’s active phase. This creates the most effective scenario, but is 
critically dependent on the absence of dark-phase light contamination, as even dim light 
during the dark phase causes the inhibition of the circadian rhythms in blood glucose, lactic 
acid, insulin and corticosteroid levels [29] which would compromise or alter the outcome of 
scientific investigations.  
Creating and using accurate and comparable models for research into MetS and associated 
CHD is essential in providing relevant and applicable data that may be extended to human 
disease state research. Basic principles such as dietary composition and fatty acids profile, 
together with appropriate husbandry practices are thus of major importance in the design 
an execution of research studies using animal models. This chapter will endeavor to 
highlight some of the crucial aspects surrounding dietary fat composition and use of the 
rodent model of diet-induced obesity and metabolic syndrome.  
2. Role of omega-6 and omega-3 fatty acids in insulin resistance and CHD 
Fatty acids are important sources of fuel as they yield large quantities of ATP when 
metabolized and the heart and skeletal muscle prefer fatty acids to glucose as fuel [30]. Fatty 
acids consist of a long aliphatic chain with a carboxylic acid group at one end and may be 
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saturated or unsaturated (those that contain no double bonds are saturated, and those that 
have double bonds are unsaturated). The biological reactivity of these compounds are 
dependent on both the length of the fatty acid chains as well as the number and positional 
location of double bonds prevalent (n-3, n-6, n-7 and n-9). An 18-carbon fatty acid 
containing two or more double bonds is referred to as being polyunsaturated fatty acids 
(PUFA), whereas fatty acids consisting of 20 or 22 carbons are termed highly unsaturated 
fatty acids (HUFA). It is especially the n-3 and n-6 HUFA that are considered to be major 
role-players affecting diet-dependent disease. These fatty acids are responsible for 
maintaining correct cell membrane protein function and fluidity and cellular functioning. 
The more highly unsaturated fatty acids, such as the n-6 arachidonic acid, are converted to 
eicosanoid derivatives which have a hormone-like action and are involved inflammatory 
pathologies such as obesity, insulin resistance and atherosclerosis [31-33]. In contrast, the n-
3 fatty acid-derived eicosanoids have anti-inflammatory and anti-thrombotic activities [34, 
35]. It is this action of the n-6 derived eicosanoids that is of particular importance as they are 
major role-players in diet-associated pathologies through their pro-inflammatory actions 
(Fig. 2). 
A number of studies, including the Seven Countries Study, have shown the Mediterranean 
Diet to be preventative of insulin resistance and CHD and protective against certain cancers 
[19, 36, 37]. This diet is characterized by a high intake of unsaturated fatty acids in the form 
of virgin olive oil containing a very low ratio of omega-6:omega-3 fatty acids (2:1). In these 
 
Figure 2. The effects of omega-6 vs. omega-3 conversion pathways on inflammation in coronary heart 
disease (adapted from [45]) 
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studies, Western diets of non-Mediterranean countries (USA, Western Europe and 
Scandinavia), and containing omega-6:omega-3 fatty acid ratios in excess of 15:1, was 
associated with significant higher incidences of insulin resistance and CHD. More 
importantly, the lack of detrimental effect of SFA and cholesterol intake, in the presence of 
optimal omega-3 intake, was simultaneously indicated [38, 39], as was the failure to 
document a relationship between dietary cholesterol and CHD (reviewed by [9]). Reducing 
SFA intake or replacing SFA with MUFA was found to not improve cardiovascular risk [40, 
41]. Moreover, blood cholesterol levels alone do not predict absolute CHD mortality rates 
observed for different groups worldwide (Fig. 3) and these death rates differ at each 
cholesterol level. In fact, the elevations in blood cholesterol are fatal only to the magnitude 
that omega-6 exceeds omega-3 in tissue HUFA [19]. It is thus not surprising that it has 
recently been proposed that omega-6 HUFA blood levels are more indicative of heart 
disease risk than total cholesterol level, where high omega-6 HUFA levels inhibits omega-3 
synthesis [42, 43]. The authors of the 25-year follow-up of the Seven Countries Study 
considered factors affecting inflammatory oxidative processes and thrombosis to be of great 
importance [44].  
 
Figure 3. Dietary fatty acid imbalances which elevate blood cholesterol are fatal only to the magnitude 
that omega-6 exceeds omega-3 in tissue HUFA (From [19]). 
Omega-6 fatty acids are further known to amplify post-prandial oxidative stress leading to 
these elevations in inflammatory vascular lesions and atherosclerosis. High percentages of 
HUFA in plasma and adipose tissue of obese children have been reported, associated with 
higher concentrations of inflammatory markers [46]. In contrast, omega-3 HUFAs prevent 
and reverse high fat diet-induced insulin resistance, in part via modulation of adipose tissue 
inflammatory product secretion patterns [11, 20, 47]. The omega-3 HUFAs act via different 
pathways to establish this protective effect by, amongst others, inhibiting the pro-
inflammatory NFB pathway due to its inhibition of SFA-activation of Toll like receptors 
(TLR) 2 and -4, with DHA being the most potent inhibitor of this pathway. The omega-3 
HUFA EPA competes for cyclooxygenase and lipooxygenase enzymes in the AA cascade, 
and in this manner reduces the production of pro-inflammatory AA-derived eicosanoids. 
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Furthermore, EPA and DHA inhibits the release of AA by inhibiting phopholipase-A2, and 
thus also reduces activation of the pro-inflammatory AA-cascade [48]. Inflammation, 
mediated via AA-derived eicosanoids, also plays a critical role in the pathophysiology of 
atherosclerosis with coronary plaques being highly inflamed with a core rich in lipids [49]. 
Recently published studies reported that the blood plasma ratio of omega-6:omega-3 plays 
an important role in endothelial function and vascular tone, and that a high ratio is 
significantly associated with a high prevalence of coronary artery lesions [50]. The plasma 
EPA/AA ratio and high-sensitivity CRP levels were further found to be independent 
predictors of the presence of complex coronary lesion. In addition, the fact that omega-3 
fatty acid supplementation improves endothelium-dependent vasodilation further supports 
the recommendation that modulation of dietary omega-6 and omega-3 fatty acids is a safe 
and necessary approach to improving vascular health and reducing the risk of CHD [51, 52].  
3. Evolution of the omega-6:omega-3 fatty acid dietary ratio 
Studies in Paleolithic nutrition and modern-day hunter-gatherer populations estimate that 
humans evolved on a diet that was much lower in saturated fatty acids than is today's diet, 
and contained small but roughly equal amounts of omega 6 and omega 3 fats [10]. The 
Paleolithic diet, also known as the Cave Man or Hunter-Gatherer diet, prevailed for about 
2.5 million years and ended 10 000 years ago with the development of agriculture [53, 54]. 
These stone age humans centered their diet on foods that could be hunted and fished, such 
as meat, offal and seafood, and could be gathered, such as eggs, insects, fruit, nuts, seeds, 
vegetables, mushrooms, herbs and spices. The proportion of nutrients, although dependent 
on latitude and other influences, consisted of roughly 20-35% each protein and 
carbohydrates and 30-60% fat. Of the total food intake 45-65% came from animal products 
and 35-55% from plant products, but it is debatable whether any grains or tubers were 
consumed [54]. Omega-3 fatty acids were found in all of these foods, and a balance existed 
between omega-3 and omega-6 for this entire period. Hunters tended to target herbivores, 
and the total carcass fat of such animals averaged about 7% compared with domesticated 
beef cows 40%, and with 35% PUFA compared with the current 7% in grain-fed beef [55]. 
Carbohydrates nearly all came from fruit and vegetables, and a small proportion from 
honey [56], thus consisting overall of low glycemic load carbohydrates.  
The modern human inherited characteristics by genetic adaptation accrued over millions of 
years of the Paleolithic Period, and the vast majority of our biochemistry and physiology are 
adapted to life conditions that existed prior to the advent of agriculture about 10 000 years 
ago. At this time humans began to cultivate plants and later to domesticate animals 
constituting the Agricultural Revolution leading to the Neolithic Period. The gradual spread 
of agriculture throughout the Old and New Worlds generally led to an increase in 
population, and demand for foodstuffs which soon led to difficulties in exploitation of game 
and wild plant food. The main dietary innovation that accompanied agriculture involved 
the introduction of cereal grains. Crop cultivation became necessary to supply in the 
increased demand for foodstuffs, leading to cereal grains becoming staple food – a 
departure from native nutrition unparalleled and unseen in other free-living primates of 
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that period [57]. Before that time, early humans did recognize that grains could be 
consumed in times of shortage, but the labor involved in milling the grains discouraged 
frequent use. The almost 60% intake of fruits and vegetables soon declined to an estimated 
20% of daily caloric intake, with cereal grains consumed in place thereof. Grains are high in 
omega-6 fatty acids and low in omega-3, and this led to the increased dietary ratio of omega-
6:omega-3 (Fig 4).  
Since this major change in the human diet, natural selection has had too little time to make 
the optimal genetic adaptations to the new dietary composition, leading to physiological 
and metabolic maladaptation [58]. These incomplete genetic changes are not seen in modern 
hunter-gatherer populations it is thus reasonable to conclude that humans are maladapted 
to diets of domesticated and processed plant foods, contributing too many of the current 
diseases of civilization. What has compounded these maladaptive consequences of the 
agricultural age, is the fact that the demand for meat in the past 50 years has led to the 
implementation of large cattle and poultry feedlots in order to provide in the increased 
demand for meat. Prior to that time, animals were pasture-reared and consumed a diet of 
green leaves high in the omega-3 fatty acid -linolenic acid (ALA) resulting in a meat ratio 
of omega-6:omega-3 of 2:1, vs. 4:1 in grain-fed meat in beef and poultry as well as eggs. 
Cattle moved from pasture to feedlots for fattening prior to slaughter lose this valuable ALA 
store, as well as EPA and DHA with the supply diminishing each day the animal spends in 
the feedlot (Fig. 5 [59]). 
 
Figure 4. Change in dietary omega-6:omega-3 ratio from the Paleolithic Period to the current dietary 
composition [10]. 
In addition to the new emphasis on grain feeds for domestic livestock, the first part of the 
20th century marked the onset of the industrial vegetable oil industry [60]. Technological 
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advancements after World War I made large-scale production of vegetable oil more efficient 
and economic. With the advent of hydrogenation of oils to increase solidification, the ALA 
content was greatly reduced leaving a high concentration LA, and hence a high omega-
6:omega-3 ratio, with similar changes in the production of other oils such as cottonseed oil, 
safflower oil and sunflower seed oil. Soy bean meal/oil forms the main constituent of 
livestock and poultry feed, shortening and margarine and it thus forms a large proportion of 
the average daily fat intake in most countries. These changes in the consumption of essential 
fatty acids throughout the 20th century was recently (2011) reported for the first time as a 
detailed quantitative analysis (Fig. 6 [61]). They found that the estimated consumption of 
soy bean oil increased in excess of 1000-fold from 1909 to 1999. This consequently led to a 3-
fold increase in the intake of LA which was the primary determinant for the declining 
percentages of omega-3 HUFAs in tissue throughout the 20th century.  
Animals have not been spared the fate of this deleterious dietary transformation, as 
presented in a very recent study which investigated the mid-life body weight of animal 
species living with or around humans in industrialized societies [5]. The authors found that 
the body weight of primates and rodents living in controlled laboratory environments, as 
well as feral rodents and domestic dogs and cats, has increased over the past few decades 
similarly to humans. Although in this study it was speculated that certain viral pathogens 
and epigenetic factors possibly could have contributed to this obesogenic effect, it is also 
highly likely that it could be due to the deleterious transformation to a high omega-6 intake 
in chow. As in the human diet, the fat content of chow has remained constant during the 
time period o.n which this study was focused. 
 
Figure 5. Rapid decline in fat-derived omega-3 stores of beef cattle receiving grain after being moved 
from pasture to feedlot (from [59]) 
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Figure 6. Changes in the estimated per capita consumption (kg/person/year) in the USA between 1909 and 
1999 of A: of major food commodities; B: Major fat commodities; C: Vegetable and seed oils (from [61]) 
Indeed the fatty acid composition of standard rodent chow has changed similarly to that of 
humans, with comparable effects on the omega-6:omega-3 ratio [62-64]. Fifty years ago, 
laboratory chow fat content consisted of the lard of animals grazing on grass which had an 
omega-6:omega-3 of less than 6:1, but since then the omega6:omega-3 ratio in the control 
rodent diet has changed from 6:1 in 1998, to 9:1 in 2002, 12.5:1 in 2006 [26]. Standard high fat 
research diets now contain omega-6:omega-3 ratios in excess of 11:1 [51]. All maintenance 
diets contain soy bean oil as their main fat source with omega-6:omega-3 ratio of 8:1 which 
is much higher than lard produced from grass-reared beef at 2:1 used before the change to 
soy bean oil (Table 1). Hydrogenated soy bean oil produces severe insulin resistance [65], 
and is thus not suitable as a source of fat for rodent maintenance diets.  
 
Fat/Oil Omega-6:omega-3 
Sunflower seed Omega-6 only 
Safflower 253:1 
Corn 83:1 
Lard 10:1 
Soy Bean 8:1 
Beef Tallow (Grain-fed) 8:1 
Milk Fat (Grain-fed) 5:1 
Beef Tallow (Grass-finished) 2:1 
Canola 2:1 
Milk Fat (Grass-finished) 1:1 
Flax Seed 0.2:1 
 
Table 1. Omega-6:omega-3 ratios of commonly-consumed fat sources in the USA [66, 67] 
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Although the evidence is now mounting and the clear link between excessive omega-6 
intake and modern Western diseases of lifestyle established, formal dietary 
recommendations (Institute of Medicine, National Academies of Science), have not 
incorporated these alarming findings. Dietary Reference Intakes (Food and Nutrition Board) 
in 2006 recommended an adequate intake of omega-6:omega-3 of 10:1, a ratio now proven to 
be deleterious to especially cardiovascular health [67]. These recommended dietary intake 
guidelines are thus in urgent need of revision to include the levels and profiles based on the 
evidence now available in literature. 
4. Rodent models for the study of insulin resistance and CHD 
Model organisms have extensive value as sentinels informing us about environmental 
factors which may potentially have an impact on humans [68]. The severity of the obesity 
epidemic has created an urgent need to study the causes and progression of the pathologies 
associated therewith such as MetS. Animal models that sufficiently mimic all the aspects of 
this syndrome, including obesity, insulin resistance, dyslipidemia and hypertension are 
required for such studies.  
A large variety of animal species have been used as models to study MetS, with varying 
degrees of success. The ideal model should be small and economical, but large enough to 
perform the required experimental procedures. Non-human primates are in many respects 
the ideal models as they are phylogenetically close to humans, consume a comparable 
omnivorous diet, and develop MetS and CHD as they age [69], but in addition to important 
ethical issues, they have an extended lifespan, are expensive to house and carry viral 
zoonoses dangerous to humans. Other animals, such as the domestic pig, the dog and the 
rabbit all provide potential as models for MetS and CHD research, but cost, cultural status 
and species-specific vulnerabilities to dietary modulation [70], place doubt on their efficacy 
for this research field. The rat, in particular, resembles the human both in physiology and 
metabolism, and follows an omnivorous diet similar to humans with whom the rat has 
spread worldwide [71]. Since the development of the first defined rat strain at the Wistar 
Institute in the 1920s, the rat has been used regularly and to great effectivity for the study of 
diet-induced obesity, insulin resistance and the disease states associated therewith, such as 
CHD [70, 72].  
Standard laboratory rat species, such as the Wistar or Sprague-Dawley strains, are 
successfully utilized for diet-induced MetS models [73]. The diets aim at reproducing high 
fat diets (HFD) similar to what is ingested in the Westernized society, i.e. a high percentage 
total fat (of calories) with a high SFA content with or without high carbohydrate content. 
Varying combinations and amounts of carbohydrates and fats are used in different studies 
[72, 74, 75], with the carbohydrates fructose or sucrose standardly used, but the fat source 
varying. Long-term feeding of these diets induce obesity, increased abdominal fat 
deposition, hyperinsulinemia, hypertension and impaired glucose tolerance in most rat and 
mouse strains [76]. Fat fractions in these diets range between 20% and 60% of energy as fat 
as either animal-derived lard or beef tallow, or plant oils such as soy bean oil, coconut oil, 
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olive oil, safflower oil [73]. The problem is that in many cases, these constituents or profile of 
the fatty acid element in the diet are not available, not taken into account or not reported in 
published literature. In fact, standard chow prepared by commercial companies contains 
fats obtained from a variety of sources, both animal and vegetable, which, considering the 
variation in omega-6:omega-3 fatty acid ratio between such foodstuffs can have far-reaching 
implications for the outcomes of studies employing these diets. This complicates the study 
of the effects of dietary fats on obesity and insulin resistance and associated disease states, 
and makes comparison between studies almost impossible. A rodent high fat diet high in 
SFA content, in the presence of a low omega-6:omega-3 ratio would not give the same 
results as a diet similar in total fat and SFA content, but with a high omega-6:omega-3 ratio. 
Even with low to moderate fat percentages (20-30%) in the presence of the recommended 
SFA content (10%), high omega-6:omega-3 ratios can lead to glucose intolerance in rodents 
indicated by decreased insulin response to intravenous glucose tolerance tests [77].  
Rodent models share many traits with human diabetic cardiomyopathy, such as left 
ventricular hypertrophy, increased ventricular stiffness, ventricular dilatation, decreased 
fatty acid uptake, cardiac inflammation and fibrosis, decreased cardiac function and 
endothelial dysfunction [72]. In the Wistar rat the onset of cardiomyopathy occurs within 7 
weeks of receiving the diet, and leads to cardiac steatosis, impaired contractile function and 
mitochondrial degeneration with increased myocardial fatty acid uptake [78]. Simple high 
fat feeding with caloric excess is thus sufficient to induce metabolic defects that area 
associated with diabetic cardiomyopathy, but isocaloric high fat diets based on saturated 
fats alone do not induce insulin resistance and in fact improve cardiac function [79, 80]. This 
could point to both the deleterious role of hyperinsulinemia and impaired glucose 
homeostasis on the development of cardiac defects due to the consumption of the Western 
Diet, or could indicate the failure to take into account the PUFA profile of said diets used in 
these studies.  
It is worthy to note the normal rat is resistant to the development of atherosclerosis, and 
simple Western high fat diets do not induce atherosclerosis in these animals. Induction of 
atherosclerosis is less easily achieved, and generally requires addition of cholesterol to the 
animal’s diet. Atherosclerosis can be induced by increasing the oxidized form of LDL in the 
blood by either increasing the total LDL while maintaining the proportion of oxidized LDL, 
or by increasing the proportion of oxidized LDL. Linoleic acid may be a factor in the 
susceptibility of LDL to oxidation as LDL is rich in LA, but the dietary content of LA differs 
in its ability to cause LDL oxidation depending on its effect on the blood lipid profile which 
in turn varies according to species. Saturated fat feeding only exacerbates an increase in LDL 
when excessive cholesterol is consumed, and in the absence of cholesterol SFA does not 
cause a rise in LDL both in rats and humans and atherosclerosis does not result [81] 
(reviewed in [82]).  
Although rodent models play a very important role in, and indeed have advanced the 
understanding of the underlying pathological mechanisms of human MetS and CHD, these 
models do have limitation and none exist that exactly phenocopies the human MetS disease 
condition. By adding dietary inconsistencies these models cannot be used to their full 
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potential and clear and transparent dietary formulations, which include the fatty acid 
profile, are crucial for providing comparable studies and thus results. Maintenance and 
Control diets should consist of the correct recommended balance of omega-6:omega-3 fatty 
acids to provide a ‘healthy’ model and control group as reference with which to compare 
dietary interventions.  
5. The circadian clock in animal models of insulin resistance and fatty 
acid metabolism 
Nutrient homeostasis in many species of vertebrates is intricately controlled by coordinated 
interactions of daily rhythms of activity and rest, feeding behavior and energy expenditure 
and storage across the daily 24h light-and-dark cycles [83]. This circadian clock, under the 
control of molecular mechanisms cycling in the suprachiasmatic nuclei (SCN) of the 
hypothalamus, plays a critical role in a diverse group of physiological processes in different 
cell types associated with insulin, glucose and fatty acid metabolism. The main factor 
responsible for synchronization of the circadian rhythm is sun light, which determines the 
precise length of the day and night in the 24 h period. This serves to orient the human or 
animal in relation to the point of day, and light is thus one of the most powerful 
synchronizers of the circadian rhythm. In the absence of pronounced SCN signals the 
circadian rhythm in peripheral tissues becomes uncoupled, resulting in aberrant cellular 
metabolism and disease risk [29, 83]. The changes in lifestyle during the past 50 years has, in 
addition to an increased intake of inappropriate, energy-dense and poor fat- and nutrient-
quality foods, also led to increased time spent awake and hence disrupted pattern of eating, 
sleeping and physical activity. This causes an asynchrony with the circadian rhythm with 
profound effects on glucose and fatty acid metabolism, which is well-described in the 
human and linked to metabolic derangements associated with and leading to increased 
adiposity and BMI [84].  
The main synchronizers of the peripheral circadian clocks are food restriction, 
glucocorticoids and melatonin [85]. Of the peripheral tissues, the adipose tissue circadian 
clock plays a fundamental role in glucose and lipid metabolism [86, 87]. Any disturbances of 
the adipocyte circadian clock van alter adipocyte responsiveness to different stimuli, i.e. 
levels of glucose, insulin and fatty acids, and can alter the level of lipogenesis and lipolysis. 
The adipokine, adiponectin, which plays an important role in insulin sensitivity, 
inflammation and fatty acid oxidation, presents a circadian rhythm similar to insulin, with 
peak levels in the early active phase and low levels in the inactive phase (Table 2). The early 
hours of the active phase are characterized by higher glucose levels and thus higher insulin 
demand in anticipation of the onset of stimulus [88-90]. At the end of the active phase and 
the start of the rest phase, insulin levels and sensitivity are low and oral or intravenous 
glucose (or consumption of a meal) leads to a significantly higher plasma glucose response. 
Accordingly, rodents respond differently by day and night to insulin and 2-deoxy-D-glucose 
with a rapid fall in blood glucose levels occurring at the end of the active phase after a 6h 
overnight fast in contrast to delayed and diminished hypoglycemia following a day time 
(inactive phase) fast [89]. Furthermore, the circulating FFA levels follow the same circadian 
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pattern as glucose and are low in the active phase and high in the inactive phase in both 
humans and rats, with an increased turnover present in humans with T2D [90, 91]. The role 
of adiponectin in FFA, insulin and glucose metabolism in context of the circadian rhythm is 
shown in Figure 7. Under normal condition, i.e. healthy diet and daily sleep-wake cycle, 
adiponectin levels are high in the early active phase which stimulates AMPK, resulting in 
increased fatty acid oxidation and energy yield, with resultant low triglyceride levels. 
Adiponectin also upregulates PI3K which further downstream contributes to the 
improvement and optimization of insulin action, thus counteracting any pro-obesogenic and 
insulin-resistance inducing effects.  
 
 Active phase Inactive phase
Glucose Low High 
Insulin High Low 
FFAs Low High 
 - Omega-6 Low High 
 - Omega-3 High Low 
 - Eicosanoids High Low 
Adiponectin High Low 
O-GlcNAc High Low 
Table 2. Circadian pattern of compounds involved in the regulation metabolic processes linked with 
metabolic homeostasis related to the development of insulin resistance and CHD. [88, 92-94]. 
Both obesity and dysregulated circadian rhythms can profoundly modulate adiponectin 
from various perspectives, all which may have bearing on the application of the rodent 
model of insulin resistance. Peak levels of corticosteroids occur at the start of the active/dark 
phase, and then fall during the light/inactive phase, reaching the lowest level just before the 
dark/light transition. Any stressor experienced at this time, be it anxiety, starvation, fear or 
pain would cause an increase in corticosteroid levels and hence release of FFAs from fat 
stores. 
The circadian rhythm of specific PUFAs is largely lacking in literature, and to our 
knowledge, only one study has been published in which the daily variation of omega-6 and 
omega-3 fatty acid levels was reported [94]. In this study only preliminary evidence is 
presented, but the fact that a differential circadian rhythm for these fatty acids was 
identified is of great possible importance and deserves further exploration. This also 
supports earlier findings that a circadian rhythm for eicosanoid production exists, with low 
levels during the inactive phase and high levels present during the active phase [92]. In light 
of the fact the plasma FFA profile represents the dietary FFA profile [77], it is likely that the 
levels omega-6 HUFAs will be increased when a diet high in omega-6 fatty acids is 
followed. As arachidonic acid, via NFkB and eicosanoid conversions products, causes a 
suppression of adiponectin, this would exaggerate and amplify the pro-diabetic, insulin 
resistance and hyperglycemic propensity of the hormonal profile of the inactive phase. This 
further suppression of adiponectin, already low at the active/inactive phase transition, 
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Figure 7. A simplified representation of the interrelation of obesity, circadian rhythm disruption and 
dietary fatty acid intake on development of metabolic perturbations related to T2D and CHD. 
would lead to down regulation of AMPK and hence increased triglyceride levels due to 
decreased fatty acid oxidation and clearance. Furthermore, this would ultimately lead to 
hyperglycemia due to the increased fatty acid-induced flux through the hexosamine 
biosynthetic pathway (HBP) which further decreases adiponectin levels, and thus increases 
its stimulating effect on liver gluconeogenesis.  
It is known that a glucose-fatty acid cycle operates in the heart and diaphragm muscle by 
decreasing the rate of oxidation of the alternative substrate in the presence of increased 
availability of the other substrate [95, 96]. In the presence of high circulating levels of FFAs, 
a decrease in the rate of carbohydrate oxidation is seen, and vice versa when high 
circulating levels of glucose prevail. It is in this context that the HBP serves as a nutrient-
sensing mechanism and both excess FFA and glucose can lead to augmented flux through 
this pathway, which ultimately plays a role in causing insulin resistance in the adipocyte, 
liver, muscle and pancreatic β-cell via reduced recruitment and translocation of GLUT4 to 
the plasma membrane [97, 98]. In the presence of excess FFA, glycolysis is inhibited distal to 
fructose-6-phosphate by increased levels of acetyl-CoA, leading to inhibition of 
pyruvatedehydrogenase, which in turn increases fructose-6-phosphate availability and thus 
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increased flux via catalyzation of glutamine:fructose 6-phosphate amido transferase (GFAT). 
This ultimately leads to accumulation of uridine-5’-disphospho-N-acetylglucosamine (UDP-
GlcNAc) levels in tissues and this is directly correlated with the degree of insulin resistance. 
UDP-GlcNAc is the end product of the HBP, and serves as a substrate for O-linked 
glycosylation (O-GlcNAc) of proteins. It is thus regarded as the mediator of the HBP flux 
and thus insulin resistance by posttranslational protein modification of the insulin receptor 
proteins (IRS-1 and IRS-2) as well as GLUT4 (reviewed in [99]). There have, however, been 
conflicting reports in literature in which the lipid supplement Intralipid (a fat emulsion used 
intravenously as source of calories for patients requiring extended periods of parenteral 
nutrition regarded as ‘safe’ by the FDA) was found to induce insulin resistance without 
increasing HBP products [100], but as Intralipid consists mainly of soy bean oil with a ratio 
of omega-6:omega-3 of 7:1 [101] it is likely that insulin resistance was mediated mainly 
through the pro-inflammatory effects of the arachidonic acid cycle (Fig. 7) and to a lesser 
extent via flux through the HBP. Circulating FFAs also invoke insulin resistance via 
upregulation of PKC/PTEN which has an inhibitory effect on IRS-1 and IRS-2, which then 
further downstream prevents translocation of GLUT4 to the plasma membrane due to 
downregulation of PI3K [102]. This places increased emphasis on the critical need of clear 
definition of the profile of fats used in research studies, as it is probable that high levels of 
omega-6 fatty acids have a differential influence on these metabolic pathways in addition to 
being intricately involved in the circadian time structure of organisms.  
In the heart, the cardiomyocyte circadian clock, in a time-of-day-dependent manner, 
regulates metabolism and ischemic tolerance similar to the regulatory roles of that of protein 
O-GlcNAcylation [93]. These variations mediate the clock-dependent regulation of O-
GlcNAc transferase and O-GlcNAcase levels and nutrient metabolism and uptake. This 
would involve the coordinated regulation of the hexosamine biosynthetic pathway and play 
an important role in not only insulin resistance [103] but also myocardial apoptosis in the 
diet-induced insulin resistant rat [104] which in turn conversely depends critically on an 
adequate dark-phase. Any stress could increase flux through the HBP, leading to 
detrimental effects on the level of the cardiomyocyte [29, 104]. As the O-GlcNAcylation of 
proteins show clear circadian patterns and is high during the active phase and low during 
the inactive phase, it is thus proposed to have major consequences in the rat model of 
insulin resistance [93]. Any stress in the rodents during the inactive phase or at the 
transition from the active to inactive phase, as frequently is the case due to overnight 
starvation and early morning sampling, would lead to an increase in glucocorticoid levels 
which not only causes increased lipolysis and FFA levels, but also leads to inappropriately 
increased O-GlcNAcylation via direct recruitment of OGT [105]. Peak levels of 
corticosteroids occur at the start of the dark phase, and then fall during the light phase 
reaching the lowest level just before dark-light transition. Early morning sampling would 
thus possibly induce bias, due to the stress associated with starving and experimental 
procedures imposed on the animal. 
A remedy for the deleterious introduction of bias, due to researcher convenience-of-
sampling time, is to reverse the light-dark cycle, so that all animal handling and procedures 
are carried out during the animal’s active phase. This constitutes the most effective scenario, 
Importance of Dietary Fatty Acid Profile and Experimental 
Conditions in the Obese Insulin-Resistant Rodent Model of Metabolic Syndrome 141 
but is exclusively dependent on the absence of dark-phase light contamination. Even dim 
light during the dark phase causes the inhibition of the circadian rhythms in blood glucose, 
lactic acid, insulin and corticosteroid levels [29] and would compromise or alter the outcome 
of scientific investigations.  
6. Conclusions 
In summary, this chapter described the importance of the dietary fatty acid profile, with 
particular reference to the ratio of omega-6:omega-3 essential fatty acids, and the role it plays 
in insulin-resistance with reference specifically to the utilization of animal research models. 
Fatty acids are well-known to play a cardinal role in lipid and glucose homeostasis, and there 
is now compelling evidence that a reduction in the intake of omega-6 fatty acids in the diet is 
crucial to prevent disease states such as insulin resistance, obesity and cardiovascular disease. 
The majority of studies in the field of diet-induced obesity are performed using the high fat 
rodent model, but consistency and comparability is severely lacking/compromised due to 
incomplete disclosure of dietary fat components, and in many cases uncontrolled variation in 
the diet due to rat chow manufacturers using different fat sources according to availability or 
personal preference. In addition, the importance of the circadian rhythm in fatty acid and 
glucose metabolism and metabolic disturbances in the rodent experimental model is 
underemphasized, and in many cases not taken into account. This too, is of concern in the 
accuracy of results expressed in such studies, especially those investigating dietary 
interventions in insulin resistance, as seen in the regulative role that the humoral factors and 
the hexosamine biosynthetic pathway plays the circadian clock of insulin, glucose and fatty 
acid metabolism. These points highlight some frequently overlooked aspects in the 
experimental use of the diet-induced rodent model for insulin resistance, T2D and CHD 
research. In order to utilize the model to its full potential, attention to the exact dietary 
composition and experimental conditions are of critical importance.  
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